Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Susceptibility of allogeneic mice to teratocarcinoma 402AX.

Immunogenetics·2012
Same author

Mouse 4T1 breast tumor model.

Current protocols in immunology·2008
Same author

H2-O inhibits presentation of bacterial superantigens, but not endogenous self antigens.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same author

MHC class II presentation of endogenous tumor antigen by cellular vaccines depends on the endocytic pathway but not H2-M.

Traffic (Copenhagen, Denmark)·2001
Same author

Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinoma.

Journal of immunology (Baltimore, Md. : 1950)·2000
Same author

Tumor cells present MHC class II-restricted nuclear and mitochondrial antigens and are the predominant antigen presenting cells in vivo.

Journal of immunology (Baltimore, Md. : 1950)·2000

Related Experiment Video

Updated: Jul 5, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

Mouse SaI sarcoma tumor model.

S Ostrand-Rosenberg1

  • 1University of Maryland Baltimore County, Baltimore, Maryland, USA.

Current Protocols in Immunology
|April 25, 2008
PubMed
Summary

This study details the establishment and methods for obtaining SaI fibrosarcoma tumor cells in mice. Researchers can use these protocols for in vivo cancer research involving solid and ascites tumor models.

Area of Science:

  • Oncology
  • Immunology
  • Transplantation Biology

Background:

  • The SaI fibrosarcoma is a transplantable tumor model derived from A/J mice.
  • This model can produce solid tumors via various inoculation routes (subcutaneous, intradermal, intramuscular) and ascites tumors via intraperitoneal inoculation.

Purpose of the Study:

  • To describe the establishment of primary solid SaI/N tumors in syngeneic mice.
  • To detail the methods for establishing and maintaining SaI ascites tumors.
  • To outline procedures for sampling in vivo-passaged SaI ascites tumor cells.

Main Methods:

  • Subcutaneous, intradermal, intramuscular, and intraperitoneal inoculation of SaI fibrosarcoma cells into syngeneic mice.
  • Establishment and serial passaging of solid and ascites tumor models.

More Related Videos

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

Published on: July 28, 2020

Related Experiment Videos

Last Updated: Jul 5, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

Published on: July 28, 2020

  • Surgical removal of tumors for cell sampling.
  • Main Results:

    • Successful establishment of solid SaI/N fibrosarcoma tumors.
    • Successful induction and maintenance of SaI ascites tumors.
    • Protocols for obtaining viable tumor cells for further analysis.

    Conclusions:

    • The described methods provide reliable protocols for generating and utilizing SaI fibrosarcoma models in vivo.
    • These established tumor models are suitable for various research applications in cancer biology and immunology.
    • The procedures facilitate the collection of tumor cells for downstream experimental analyses.